Niels Kristian Aagaard
Overview
Explore the profile of Niels Kristian Aagaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
577
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Risbjerg R, Aagaard N, Gronbaek L, Hansen S, Kongstad K, Kazankov K
Ugeskr Laeger
. 2025 Jan;
186(51).
PMID: 39749629
Immunotherapy-induced hepatitis is a well-known and relatively common side effect of immune checkpoint inhibitors. It is usually mild to moderate and responds well to corticosteroids with a full recovery. However,...
2.
Aamann L, Dam G, Jepsen P, Borre M, Drljevic-Nielsen A, Overgaard K, et al.
J Gastroenterol Hepatol
. 2023 Feb;
38(8):1365-1371.
PMID: 36740964
Background And Aim: Physical activity confers health benefits in many diseases but remains almost unstudied for cirrhosis. We investigated whether a period of resistance training affects the subsequent long-term risk...
3.
Mikkelsen A, Thomsen K, Vilstrup H, Aagaard N
Metab Brain Dis
. 2022 Nov;
38(5):1765-1768.
PMID: 36326977
Patients with cirrhosis are prone to electrolyte disorders, including hypokalaemia. The available evidence suggests that hypokalaemia facilitates hyperammonaemia and thus increases the risk for hepatic encephalopathy (HE). In case studies,...
4.
Gantzel R, Aagaard N, Vilstrup H, Watson H, Gronbaek H, Jepsen P
Hepatol Commun
. 2022 Aug;
6(11):3175-3185.
PMID: 35972345
Ascites formation is a sign of decompensation of cirrhosis and heralds a poor prognosis. The widely used standard binary classification of ascites as diuretic-responsive or refractory does not cover the...
5.
Gantzel R, Kjaer M, Jepsen P, Aagaard N, Watson H, Gluud L, et al.
World J Hepatol
. 2022 Jun;
14(4):827-845.
PMID: 35646272
Background: Natriuretic peptides are involved in the cascade of pathophysiological events occurring in liver cirrhosis, counterbalancing vasoconstriction and anti-natriuretic factors. The effects of natriuretic peptides as treatment of cirrhotic ascites...
6.
Aagaard N, Malago M, De Gottardi A, Thomas M, Sauter G, Engelmann C, et al.
BMC Gastroenterol
. 2022 Mar;
22(1):111.
PMID: 35260086
Background: The alfapump is an implantable class III medical device that pumps ascitic fluid from the peritoneal space to the urinary bladder from where it is excreted. The pump reduces...
7.
Gantzel R, Meyer M, Mazgareanu S, Aagaard N, Jepsen P, Holzmeister J, et al.
Dan Med J
. 2021 Dec;
68(12).
PMID: 34851251
INTRODUCTION Ascites is a frequent complication to cirrhosis. When ascites becomes refractory to standard diuretic pharmacotherapy, patients are facing a median survival of less than one year and most likely...
8.
Rittig N, Aagaard N, Villadsen G, Sandahl T, Jessen N, Gronbaek H, et al.
Aliment Pharmacol Ther
. 2021 Jul;
54(3):347.
PMID: 34236099
No abstract available.
9.
Rittig N, Aagaard N, Villadsen G, Sandahl T, Jessen N, Gronbaek H, et al.
Aliment Pharmacol Ther
. 2021 Jun;
54(3):320-328.
PMID: 34165199
Background: Portal hypertension is the main determinant of clinical decompensation in patients with liver cirrhosis. In preclinical data metformin lowers portal pressure, but there are no clinical data for this...
10.
Kraglund F, Gantzel R, Jepsen P, Aagaard N
J Hepatol
. 2021 Apr;
75(3):746-747.
PMID: 33915238
No abstract available.